References
- Park SW, Lee SG, Song SH, Heo DS, Park BJ, Lee DW, Kim KH, Sung MW: The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines. Int J Cancer 2003;107:729-738 https://doi.org/10.1002/ijc.11498
- Swamy MV, Cooma I, Patlolla JM, Simi B, Reddy BS, Rao CV: Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment. Mol Cancer Ther 2004;3:215-221
- Wei M, Morimura K, Wanibuchi H, Shen J, Doi K, Mitsuhashi M, Moku M, Salim EI, Fukushima S: Chemopreventive effect of JTE- 522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine- induced rat colon carcinogenesis. Cancer Lett 2003;202:11- 16 https://doi.org/10.1016/S0304-3835(03)00477-4
- Wu J, Xia HH, Tu SP, Fan DM, Lin MC, Kung HF, Lam SK, Wong BC: 15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitorinduced apoptosis in gastric cancer. Carcinogenesis 2003;24:243-247 https://doi.org/10.1093/carcin/24.2.243
- Kawamori T, Uchiya N, Kitamura T, Ohuchida S, Yamamoto H, Maruyama T, Sugimura T, Wakabayashi K: Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis. Anticancer Res 2001;21:3865-3869
- Kismet K, Akay MT, Abbasoglu O, Ercan A: Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect Prev 2004;28:127-142 https://doi.org/10.1016/j.cdp.2003.12.005
- Kitamura T, Itoh M, Noda T, Matsuura M, Wakabayashi K: Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Int J Cancer 2004;109:576-580 https://doi.org/10.1002/ijc.20012
- Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ: Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Res 2004;64:1181-1189 https://doi.org/10.1158/0008-5472.CAN-03-2556
- Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE: Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis. Anticancer Res 2001;21:3425-3432
- Yoshida K, Tanaka T, Kohno H, Sakata K, Kawamori T, Mori H, Wakabayashi K: A COX-2 inhibitor, nimesulide, inhibits chemicallyinduced rat tongue carcinogenesis through suppression of cell proliferation activity and COX-2 and iNOS expression. Histol Histopathol 2003;18:39-48
- Furukawa F, Nishikawa A, Lee IS, Kanki K, Umemura T, Okazaki K, Kawamori T, Wakabayashi K, Hirose M: A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2- oxopropyl)amine-induced pancreatic carcinogenesis in hamsters. Int J Cancer 2003;104:269-273 https://doi.org/10.1002/ijc.10965
- Carlton PS, Gopalakrishnan R, Gupta A, Liston BW, Habib S, Morse MA, Stoner GD: Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine- induced tumorigenesis in the rat esophagus. Cancer Res 2002;62:4376-4382
- Badawi AF, Badr MZ: Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptorgamma (Review). Int J Oncol 2002;20:1109-1122. Review
- Buttar NS, Wang KK, Leontovich O, Westcott JY, Pacifico RJ, Anderson MA, Krishnadath KK, Lutzke LS, Burgart LJ:Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002;122:1101-1112 https://doi.org/10.1053/gast.2002.32371
- Ogino S, Kawasaki T, Kirkner GJ, Yamaji T, Loda M, Fuchs CS: Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP. Mod Pathol 2007; 20:15- 22 https://doi.org/10.1038/modpathol.3800709
- Soo R, Wu J, Aggarwal A, Tao Q, Hsieh W, Putti T, Tan K, Soon W, Lai Y, Mow B, Hsu S, Loh K, Tan L, Tan P, Goh BC: Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression. Ann Oncol 2006;17:1625-1630 https://doi.org/10.1093/annonc/mdl283
- Gately S, Kerbel R: Therapeutic potential of selective cyclooxygenase- 2 inhibitors in the management of tumor angiogenesis. Prog Exp Tumor Res 2003;37:179-192. Review https://doi.org/10.1159/000071373